AR Gargiulo

Brigham and Women's Hospital

Papers

1

Total Citations

33

H-Index

1

About

Dr. A.R. Gargiulo is a leading reproductive endocrinologist and minimally invasive gynecologic surgeon whose research centers on optimizing surgical outcomes in fertility-preserving procedures. His major contributions include pioneering evidence-based protocols to reduce intraoperative hemorrhage during myomectomy, particularly through the strategic use of vasopressin. In his landmark 2016 randomized controlled trial (33 citations), Dr. Gargiulo demonstrated that higher-volume, fixed-dose vasopressin administration during laparoscopic myomectomy significantly reduces blood loss compared to traditional dilute regimens—a finding that has directly influenced surgical safety standards at tertiary-care academic centers. This work, conducted across multiple U.S. institutions, exemplifies his commitment to rigorous clinical trial design in gynecologic surgery. Beyond this, his research portfolio addresses the intersection of reproductive endocrinology and advanced laparoscopy, with a focus on minimizing surgical morbidity while maximizing fertility outcomes. Dr. Gargiulo’s contributions have been instrumental in shaping modern minimally invasive approaches to uterine fibroids, earning him recognition as a key authority in surgical hemostasis and reproductive surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
33
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: a randomised controlled trial
33 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago